Effective January 1, 2008, natalizumab (J2323), will be available through the Medicare Part B Drug Competitive Acquisition Program (CAP).
As a result, an additional election period for the 2008 CAP will begin on January 15, 2008 and will conclude on February 15, 2008. The CAP is a voluntary program that offers physicians the option to acquire many injectable and infused drugs used in their practice from an Approved CAP Vendor.
This additional election period is for physicians who are not currently participating in the CAP for 2008. Effective dates of participation for physicians who elect to join the CAP during this additional election period will be April 1, 2008, to December 31, 2008.